| Source: |
| Type: |
| Fatty Acid Metabolism - Fatty Acid Synthesis, Uptake, Transport, and Oxidation Type: Metabolic pathway / lipid metabolism pathway Function: Fatty acid metabolism encompasses the uptake, intracellular transport, de novo synthesis, elongation, desaturation, storage, mobilization, and mitochondrial or peroxisomal oxidation of fatty acids. Major regulatory components include SREBP-1/SREBF1, ACLY, ACACA/ACC, FASN, SCD, FABPs, CD36, ACSL enzymes, CPT1, and enzymes of mitochondrial β-oxidation. The pathway supplies membrane lipids, signaling molecules, ATP, reducing equivalents, and metabolic intermediates. Cancer: ↑ / reprogrammed. Cancer cells frequently increase fatty-acid uptake, de novo lipogenesis, and/or fatty-acid oxidation to meet demands for membrane synthesis, energy production, redox homeostasis, survival, and signaling. Altered fatty-acid metabolism can promote proliferation, cancer stemness, invasion, metastasis, immune evasion, ferroptosis resistance, and treatment resistance. The dominant branch varies by tumor type and metabolic environment. Alzheimer's Disease: ↕ Dysregulated. Alzheimer's disease is associated with altered fatty-acid composition, polyunsaturated fatty-acid metabolism, lipid transport, mitochondrial fatty-acid utilization, and membrane lipid homeostasis. These abnormalities can influence mitochondrial function, amyloid-β metabolism, tau pathology, neuroinflammation, synaptic function, and oxidative stress. Because individual fatty acids and metabolic branches may change in opposite directions, a single increase or decrease does not adequately describe the pathway. |
| 7757- | ISL, | Isoliquiritigenin Suppresses Oral Squamous Cell Carcinoma Progression by Targeting FABP5-Mediated Lipid Metabolism: Association with the circPOLB/miR-548ae-3p/C-MYC Axis |
| - | in-vitro, | Oral, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1693 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid